Morgan Stanley Schedule 13G passive stakes

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have disclosed a 6.1% beneficial ownership stake in Neuberger Berman Energy Infrastructure & Income Fund Inc. as of June 30, 2025.

Morgan Stanley and its subsidiary, Morgan Stanley & Co. International plc, have reported a combined beneficial ownership of 6.3% in Criteo S.A. as of June 30, 2025.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, report a 6.6% beneficial ownership stake in Nuveen Taxable Municipal Income Fund.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, reported a 15.6% beneficial ownership stake in Western Asset Premier Bond Fund.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have reduced their beneficial ownership in JBG SMITH Properties to below 5% of common shares.

Morgan Stanley has disclosed a 6.7% beneficial ownership stake in CEVA INC's common stock, held in the ordinary course of business.

Morgan Stanley and its subsidiary have disclosed beneficial ownership of 8.4% of Chemomab Therapeutics Ltd.'s Ordinary Shares/American Depositary Shares.

Morgan Stanley and its subsidiary Parametric Portfolio Associates LLC have disclosed a 5.1% beneficial ownership stake in First Trust Senior Floating Rate Income Fund II.

Morgan Stanley and its investment management arm have reduced their beneficial ownership in PROKIDNEY CORP. to below the 5% reporting threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have disclosed a 5.8% beneficial ownership stake in Semler Scientific, Inc. common stock.

Morgan Stanley and its subsidiary have reduced their beneficial ownership in TAL Education Group's Class A Common Shares to below 5%.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have disclosed a 14.8% beneficial ownership in RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.'s Series B Preferred Shares.

Morgan Stanley has disclosed a 5.0% passive beneficial ownership stake in Jasper Therapeutics, Inc. as of June 30, 2025.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have disclosed a passive beneficial ownership of 7.1% of IonQ, Inc.'s common stock.

Morgan Stanley and its subsidiary have disclosed a 7.0% beneficial ownership stake in Evolent Health, Inc.'s Class A Common Stock, held for passive investment purposes.

Morgan Stanley and its subsidiary have reported beneficial ownership of 8.5% of Grove Collaborative Holdings, Inc.'s Class A Common Stock.

Morgan Stanley has disclosed a 5.4% beneficial ownership stake in UroGen Pharma Ltd.'s Ordinary Shares, held in the ordinary course of business.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have disclosed a 6.2% beneficial ownership stake in QXO, Inc. common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have reported beneficial ownership of 5.1% of Samsara Inc.'s Class A Common Stock.

Morgan Stanley and its subsidiary Parametric Portfolio Associates LLC report a combined 11.3% beneficial ownership in Virtus Convertible & Income Fund II.

Morgan Stanley has reported a 5.8% beneficial ownership stake in Sprout Social, Inc.'s Class A Common Stock as of June 30, 2025.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have disclosed a 6.3% beneficial ownership stake in Highland Opportunities & Income Fund.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have disclosed a 6.5% beneficial ownership stake in Royce Global Trust, Inc. common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have disclosed a passive beneficial ownership of 6.7% in Taysha Gene Therapies, Inc. common stock.

Morgan Stanley has reported a 6.1% passive beneficial ownership stake in Pliant Therapeutics, Inc., holding 3,737,335 shares of common stock.

Morgan Stanley has disclosed a 5.4% beneficial ownership stake in Magnera Corp's common stock, holding 1,937,474 shares as of June 30, 2025.

Morgan Stanley and its subsidiary report a 15.9% beneficial ownership stake in MFS Charter Income Trust, totaling 6,676,108 shares.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have disclosed a 6.9% beneficial ownership stake in Virtus Convertible & Income Fund II's Series A Cumulative Preferred Shares.

Morgan Stanley and its subsidiary have reduced their beneficial ownership in Eaton Vance Floating-Rate Income Trust to below 5%.

Morgan Stanley and its subsidiary, Atlanta Capital Management, have disclosed increased beneficial ownership in Carlisle Companies Inc., reaching 6.4% and 5.7% respectively.